Answers are grounded in this paper and cite their sources.
Cross-sectional study compares procalcitonin and C-reactive protein in diagnosing neonatal sepsis, suggesting PCT is more accurate.
Background: Neonatal sepsis remains a major contributor to neonatal morbidity and mortality worldwide. Timely and accurate diagnosis, followed by prompt treatment, is critical for improving neonatal survival. Objective: To compare the diagnostic accuracy of procalcitonin (PCT) and C-reactive protein (CRP) in neonates with suspected sepsis. Methodology: This cross-sectional study was conducted in the Microbiology Department from March 2024 to August 2024. A total of 88 neonates (aged ≤28 days) with two or more clinical signs of sepsis were included using a non-probability convenience sampling technique. Data collected included demographic details, clinical examination findings, blood culture results, and quantitative values of PCT and CRP. Results: The mean age of neonates was 6.10 ± 2.64 days. Among them, 56 (63.6%) were males and 32 (36.4%) were females. The most frequent clinical finding was low birth weight (39, 44.3%), followed by prematurity (35, 39.8%). Using blood culture as the gold standard, PCT demonstrated higher diagnostic accuracy (55.68%) compared to CRP (37.5%). Sensitivity and specificity of PCT were 74.3% and 43.4%, respectively, while those of CRP were 56.6% and 19.3%, respectively. Positive blood cultures were found in 35 (39.8%) neonates, with Klebsiella pneumoniae being the most common organism (14, 15.9%), followed by Acinetobacter baumannii (10, 11.4%) and Escherichia coli (7, 8%). Conclusion: Procalcitonin is a more reliable biomarker than C-reactive protein for diagnosing neonatal sepsis. Its use may support earlier diagnosis and targeted interventions, potentially improving neonatal outcomes.
No takes yet. Share an insight, caveat, or question.
Shaukat et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: